HPA-axis hyperactivity and mortality in psychotic depressive disorder: Preliminary findings

Psychoneuroendocrinology

Volumn 33, Issue 5, 2008, Pages 654-658

  Coryell, William ^a   Fiedorowicz, Jess ^a   Zimmerman, Mark ^b   Young, Elizabeth ^c  

^a UNIVERSITY OF IOWA   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Cardiovascular mortality; Hypothalamic pituitary adrenal axis; Major depression with psychotic features; Suicide

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DEPRESSIVE PSYCHOSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HYPERACTIVITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MORTALITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; SCHIZOAFFECTIVE PSYCHOSIS; SUICIDE; TIME;

ADULT; AGE FACTORS; AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DEPRESSIVE DISORDER, MAJOR; DEXAMETHASONE; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; PREDICTIVE VALUE OF TESTS; PSYCHOTIC DISORDERS; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; SUICIDE; TIME FACTORS; UNITED STATES;

EID: 42749094085     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2008.02.005     Document Type: Article

References (45)

1. Allgulander C. Suicide and mortality patterns in anxiety neurosis and depressive neurosis. Arch. Gen. Psychiatry 51 (1994) 708-712
2. Aromaa A., Raitasalo R., Reunanen A., Impivaara O., Heliovaara M., Knekt P., Lehtinen V., Joukamaa M., and Maatela J. Depression and cardiovascular diseases. Acta. Psychiatr. Scand. Suppl. 377 (1994) 77-82
3. Barefoot J.C., and Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 93 (1996) 1976-1980
4. Black D.W., Monahan P.O., and Winokur G. The relationship between DST results and suicidal behavior. Ann. Clin. Psychiatry 14 (2002) 83-88
5. Broadley A.J., Korszun A., Abdelaal E., Moskvina V., Deanfield J., Jones C.J., and Frenneaux M.P. Metyrapone improves endothelial dysfunction in patients with treated depression. J. Am. Coll. Cardiol. 48 (2006) 170-175
6. Brown R.P., Stoll P.M., Stokes P.E., Frances A., Sweeney J., Kocsis J.H., and Mann J.J. Adrenocortical hyperactivity in depression: effects of agitation, delusions, melancholia, and other illness variables. Psychiatry Res. 23 (1988) 167-178
7. Carroll B.J., Greden J.F., and Feinberg M. Suicide, neuroendocrine dysfunction and CSF 5-HIAA concentrations in depression. In: Angrist M. (Ed). Recent Advances in Neuropsychopharmacology (1980), Pergoman Press, Oxford 307-313
8. Coryell W., and Schlesser M.A. Suicide and the dexamethasone suppression test in unipolar depression. Am. J. Psychiatry 138 (1981) 1120-1121
9. Coryell W., and Schlesser M. The dexamethasone suppression test and suicide prediction. Am. J. Psychiatry 158 (2001) 748-753
10. Coryell W.H., and Zimmerman M. HPA axis hyperactivity and recovery from functional psychoses. Am. J. Psychiatry 146 (1989) 473-477
11. Coryell W., Pfohl B., and Zimmerman M. The clinical and neuroendocrine features of psychotic depression. J. Nerv. Ment. Dis. 172 (1984) 521-528
12. Coryell W., Zimmermann M., Winokur G., and Cadoret R. Baseline neuroendocrine function and diagnostic stability among patients with a non-manic psychosis. Eur. Arch. Psychiatry Neurol. Sci. 237 (1988) 197-199
13. Coryell W., Keller M., Lavori P., and Endicott J. Affective syndromes, psychotic features, and prognosis. I. Depress. Arch. Gen. Psychiatry 47 (1990) 651-657
14. Coryell W., Young E., and Carroll B. Hyperactivity of the hypothalamic-pituitary-adrenal axis and mortality in major depressive disorder. Psychiatry Res. 142 (2006) 99-104
15. Endicott J., and Spitzer R.L. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch. Gen. Psychiatry 35 (1978) 837-844
16. Evans D.L., and Nemeroff C.B. The clinical use of the dexamethasone suppression test in DSM-III affective disorders: correlation with the severe depressive subtypes of melancholia and psychosis. J. Psychiatr. Res. 21 (1987) 185-194
17. Everson S.A., Goldberg D.E., Kaplan G.A., Cohen R.D., Pukkala E., Tuomilehto J., and Salonen J.T. Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom. Med. 58 (1996) 113-121
18. Goodyer I.M., Herbert J., Tamplin A., and Altham P.M. Recent life events, cortisol, dehydroepiandrosterone and the onset of major depression in high-risk adolescents. Br. J. Psychiatry 177 (2000) 499-504
19. Harris T.O., Borsanyi S., Messari S., Stanford K., Cleary S.E., Shiers H.M., Brown G.W., and Herbert J. Morning cortisol as a risk factor for subsequent major depressive disorder in adult women. Br. J. Psychiatry 177 (2000) 505-510
20. Holsboer F., Lauer C.J., Schreiber W., and Krieg J.C. Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. J. Neuroendocrinol. 62 (1995) 340-347
21. Holsboer F., von Bardeleben U., Wiedemann K., Muller O.A., and Stalla G.K. Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression. Biol. Psychiatry 22 (1987) 228-234
22. Jokinen J., Carlborg A., Martensson B., Forslund K., Nordstrom A.L., and Nordstrom P. DST non-suppression predicts suicide after attempted suicide. Psychiatry Res. 150 (2007) 297-303
23. Jokinen J., Nordstrom A.L., and Nordstrom P. ROC analysis of dexamethasone suppression test threshold in suicide prediction after attempted suicide. J. Affect. Disord. 106 (2008) 145-152
24. Kathol R.G. Persistent elevation of urinary free cortisol and loss of circannual periodicity in recovered depressive patients. A trait finding. J. Affect. Disord. 8 (1985) 137-145
25. Levy A.B., and Stern S.L. DST and TRH stimulation test in mood disorder subtypes. Am. J. Psychiatry 144 (1987) 472-475
26. Mann J.J., Currier D., Stanley B., Oquendo M.A., Amsel L.V., and Ellis S.P. Can biological tests assist prediction of suicide in mood disorders?. Int. J. Neuropsychopharmacol. 9 (2006) 465-474
27. Murphy J.M., Monson R.R., Olivier D.C., Sobol A.M., and Leighton A.H. Affective disorders and mortality. A general population study. Arch. Gen. Psychiatry 44 (1987) 473-480
28. Musselman D.L., Evans D.L., and Nemeroff C.B. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch. Gen. Psychiatry 55 (1998) 580-592
29. Nelson J.C., and Davis J.M. DST studies in psychotic depression: a meta-analysis. Am. J. Psychiatry 154 (1997) 1497-1503
30. Norman W.H., Brown W.A., Miller I.W., Keitner G.I., and Overholser J.C. The dexamethasone suppression test and completed suicide. Acta. Psychiatr. Scand. 81 (1990) 120-125
31. Norton B., and Whalley L.J. Mortality of a lithium-treated population. Br. J. Psychiatry 145 (1984) 277-282
32. Rebuffe-Scrive M., Bronnegard M., Nilsson A., Eldh J., Gustafsson J.A., and Bjorntorp P. Steroid hormone receptors in human adipose tissues. J. Clin. Endocrinol. Metab. 71 (1990) 1215-1219
33. Ribeiro S.C., Tandon R., Grunhaus L., and Greden J.F. The DST as a predictor of outcome in depression: a meta-analysis. Am. J. Psychiatry 150 (1993) 1618-1629
34. Rothschild A.J., Schatzberg A.F., Rosenbaum A.H., Stahl J.B., and Cole J.O. The dexamethasone suppression test as a discriminator among subtypes of psychotic patients. Br. J. Psychiatry 141 (1982) 471-474
35. Targum S.D., Rosen L., and Capodanno A.E. The dexamethasone suppression test in suicidal patients with unipolar depression. Am. J. Psychiatry 140 (1983) 877-879
36. Thakore J.H., Richards P.J., Reznek R.H., Martin A., and Dinan T.G. Increased intra-abdominal fat deposition in patients with major depressive illness as measured by computed tomography. Biol. Psychiatry 41 (1997) 1140-1142
37. Tsuang M.T., Woolson R.F., and Fleming J.A. Premature deaths in schizophrenia and affective disorders. An analysis of survival curves and variables affecting the shortened survival. Arch. Gen. Psychiatry 37 (1980) 979-983
38. Vogelzangs N., Suthers K., Ferrucci L., Simonsick E.M., Ble A., Schrager M., Bandinelli S., Lauretani F., Giannelli S.V., and Penninx B.W. Hypercortisolemic depression is associated with the metabolic syndrome in late-life. Psychoneuroendocrinology 32 (2007) 151-159
39. Vythilingam M., Chen J., Bremner J.D., Mazure C.M., Maciejewski P.K., and Nelson J.C. Psychotic depression and mortality. Am. J. Psychiatry 160 (2003) 574-576
40. Wang M. The role of glucocorticoid action in the pathophysiology of the metabolic syndrome. Nutr. Metab. (Lond.) 2 (2005) 3
41. Weber-Hamann B., Hentschel F., Kniest A., Deuschle M., Colla M., Lederbogen F., and Heuser I. Hypercortisolemic depression is associated with increased intra-abdominal fat. Psychosom. Med. 64 (2002) 274-277
42. Weber-Hamann B., Werner M., Hentschel F., Bindeballe N., Lederbogen F., Deuschle M., and Heuser I. Metabolic changes in elderly patients with major depression: evidence for increased accumulation of visceral fat at follow-up. Psychoneuroendocrinology 31 (2006) 347-354
43. Weber B., Schweiger U., Deuschle M., and Heuser I. Major depression and impaired glucose tolerance. Exp. Clin. Endocrinol. Diabetes 108 (2000) 187-190
44. Yerevanian B.I., Feusner J.D., Koek R.J., and Mintz J. The dexamethasone suppression test as a predictor of suicidal behavior in unipolar depression. J. Affect. Disord. 83 (2004) 103-108
45. Young E.A., Aggen S.H., Prescott C.A., and Kendler K.S. Similarity in saliva cortisol measures in monozygotic twins and the influence of past major depression. Biol. Psychiatry 48 (2000) 70-74